ELUTIA INC. — Director's Dealing 2022

Dec 15, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AZIYO BIOLOGICS, INC. (AZYO)
CIK: 0001708527
Period of Report: 2022-12-05

Reporting Person: HighCape Partners GP II, LLC (10% Owner)
Reporting Person: HighCape Partners GP II, L.P. (10% Owner)
Reporting Person: HighCape Partners QP II, L.P. (10% Owner)
Reporting Person: HighCape Partners II, L.P. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	735000	Indirect

Footnotes

F1: Includes 15,023 shares of Class A Common Stock held of record by HighCape Partners II, L.P. and 719,977 shares of Class A Common Stock held of record by HighCape Partners QP II, L.P.

F2: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP II, LLC, which is the general partner of HighCape Partners GP II, L.P., which is the general partner of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P.

F3: The securities reported herein do not include: (i) 53,818 shares of Class A Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Class A Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Class A Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Class A Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; and (v) 48,931 shares of Class A Common Stock held of record by HighCape Capital, L.P., which securities were included on a Form 4 filed by those entities on December 7, 2022.